For Media

Argos Therapeutics, Inc. is developing fully personalized immunotherapies that target unique features of a patient’s disease. This new generation of personalized therapeutics trains the immune system to recognize and attack diseases. Argos’ scientific leadership in RNA-loaded dendritic cells and advanced manufacturing processes provide a platform that we believe can tackle a wide range of cancers and infectious diseases.

Argos Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference
Read more

Argos Therapeutics Receives 2014 Red Herring North America Top 100 Award
Read more

Argos Therapeutics Reports Third Quarter 2014 Financial Results and Operational Highlights
Read more